|
[1]
|
Hansen, J.C., Gilman, A.P. and Odland, J.O. (2010) Is thermogenesis a significant causal factor in preventing the “globesity” epidemic? Medical Hypotheses, 75, 250- 256. doi:10.1016/j.mehy.2010.02.033
|
|
[2]
|
Businaro, R., Ippoliti, F., Ricci, S., Canitano, N. and Fuso, A. (2012) Alzheimer’s disease promotion by obesity: In- duced mechanisms-molecular links and perspectives. Current Gerontology and Geriatrics Re-search, 2012, 986823.
|
|
[3]
|
Misiak, B., J. Leszek, and Kiejna, A. (2012) Metabolic syndrome, mild cognitive impairment and Alzheimer’s disease—The emerging role of systemic low-grade in- flammation and adiposity. Brain Research Bulletin, 89, 144-149. doi:10.1016/j.brainresbull.2012.08.003
|
|
[4]
|
Luchsinger, J.A. and Mayeux, R. (2007) Adiposity and Alzheimer’s disease. Current Alzheimer Research, 4, 127- 134. doi:10.2174/156720507780362100
|
|
[5]
|
Petanceska, S.S. (2007) Exploring the links between obe- sity and Alzheimer’s disease. Current Alzheimer Research, 4, 95-96. doi:10.2174/156720507780362218
|
|
[6]
|
Whitmer, R.A. (2007) The epidemiology of adiposity and dementia. Current Alzheimer Research, 4, 117-122.
doi:10.2174/156720507780362065
|
|
[7]
|
Wolozin, B. and Bednar, M.M. (2006) Interventions for heart disease and their effects on Alzheimer’s disease. Neurology Research, 28, 630-636.
doi:10.1179/016164106X130515
|
|
[8]
|
Whalley, L.J., Dick, F.D. and McNeill, G. (2006) A life-course approach to the aetiology of late-onset dementias. The Lancet Neurology, 5, 87-96.
doi:10.1016/S1474-4422(05)70286-6
|
|
[9]
|
Weih, M., Wiltfang, J. and Kornhuber, J. (2007) Non- pharmacologic prevention of Alzheimer’s disease: Nutri- tional and life-style risk factors. Journal of Neural Trans- mission, 114, 1187-1197. doi:10.1007/s00702-007-0704-x
|
|
[10]
|
De Mendonca, A.V., 3rd European symposium on Alz- heimer’s disease prevention, Lisbonne, June 1st 2007. The Journal of Nutrition Health and Aging, 12, 50S.
doi:10.1007/BF02982586
|
|
[11]
|
Xu, W.L., Atti, A.R., Gatz, M., Pedersen, N.L., Johansson, B. and Fratiglioni, L. (2011) Midlife overweight and obe- sity increase late-life dementia risk: A population-based twin study. Neurology, 76, 1568-1574.
doi:10.1212/WNL.0b013e3182190d09
|
|
[12]
|
Fitzpatrick, A.L., Kuller, L.H., Lopez, O.L., Diehr, P., O’Meara, E.S., Longstreth Jr., W.T., et al. (2009) Midlife and late-life obesity and the risk of dementia: cardiovas- cular health study. Archives of Neurology, 66, 336-342.
doi:10.1001/archneurol.2008.582
|
|
[13]
|
Gustafson, D., Rothen-berg, E., Blennow, K., Steen, B. and Skoog, I. (2003) An 18-year follow-up of overweight and risk of Alzheimer disease. Archives of Internal Medi- cine, 163, 1524-1528. doi:10.1001/archinte.163.13.1524
|
|
[14]
|
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kareholt, I. Winblad, B., et al. (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Archives of Neurology, 62, 1556-1560.
doi:10.1001/archneur.62.10.1556
|
|
[15]
|
Balakrishnan, K., Verdile, G., Mehta, P.D., Beilby, J., No- lan, D., Galvao, D.A., et al. (2005) Plasma Abeta42 correlates positively with increased body fat in healthy indi- viduals. Journal of Alzheimer’s Disease, 8, 269-282.
|
|
[16]
|
Hendrie, H.C., Ogunniyi, A., Hall, K.S., Baiyewu, O.F.W., Unverzagt, O., Gureje, et al., (2001) Inci-dence of demen- tia and Alzheimer disease in 2 communities: Yoruba re- siding in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA, 285, 739-747.
doi:10.1001/jama.285.6.739
|
|
[17]
|
Graves, A.B., Rajaram, L., Bowen, J.D., McCormick, W.C., McCurry, S.M. and Larson, E.B. (1999) Cognitive decline and Japanese culture in a cohort of older Japanese Americans in King County, WA: The Kame Project. The Journals of Gerontology. Series B, Psychological Sci- ences and Social Sciences, 54, S154-S161.
doi:10.1093/geronb/54B.3.S154
|
|
[18]
|
Engelhart, M.J., Geer-lings, M.I., Ruitenberg, A., Van Swieten, J.C., Hofman, A., Witteman, J.C., et al. (2002) Diet and risk of dementia: Does fat matter: The Rotterdam study. Neurology, 59, 1915-1921.
doi:10.1212/01.WNL.0000038345.77753.46
|
|
[19]
|
Pasinetti, G.M., Zhao, Z., Qin, W., Ho, L., Shrishailam, Y., Macgrogan, D., et al. (2007) Caloric intake and Alz- heimer’s disease. Experimental approaches and therapeutic implications. Interdis-ciplinary Topics in Gerontology, 35, 159-175.
|
|
[20]
|
Greenwood, C.E. and Winocur, G. (1990) Learning and memory impairment in rats fed a high saturated fat diet. Behavioral and Neural Bi-ology, 53, 74-87.
doi:10.1016/0163-1047(90)90831-P
|
|
[21]
|
Martins, I.J. and Redgrave, T.G. (2004) Obesity and post- prandial lipid metabo-lism. Feast or famine? The Journal of Nutritional Biochemistry, 15, 130-141.
doi:10.1016/j.jnutbio.2003.10.006
|
|
[22]
|
Howard, B.V. (1999) Insulin resistance and lipid metabo- lism. American Journal of Cardiology, 84, 28J-32J.
doi:10.1016/S0002-9149(99)00355-0
|
|
[23]
|
Couillard, C., Bergeron, N., Bergeron, J., Pascot, A., Mau- riege, P., Tremblay, A., et al. (2000) Metabolic heteroge- neity underlying post-prandial lipemia among men with low fasting high density lipoprotein cholesterol concen- trations. The Journal of Clinical Endocrinology & Meta- bolism, 85, 4575-4582. doi:10.1210/jc.85.12.4575
|
|
[24]
|
Maesako, M., Uemura, K., Kubota, M., Kuzuya, A., Sa- saki, K., Hayashida, N., et al. (2012) Exercise is more ef- fective than diet control in preventing high fat diet-induced beta-amyloid deposition and memory deficit in amy- loid precursor protein transgenic mice. The Journal of Bio- logical Chemistry, 287, 23024-23033.
doi:10.1074/jbc.M112.367011
|
|
[25]
|
Maesako, M., Uemura, K., Kubota, M., Kuzuya, A., Sa- saki, K., Asada, M., et al. (2012) Environmental enrich- ment ameliorated high-fat diet-induced Abeta deposition and memory deficit in APP transgenic mice. Neurobiol- ogy of Aging, 33, e11-e23.
|
|
[26]
|
Boden, G. (1998) Free Fatty Acids (FFA), a link between obesity and insulin re-sistance. Frontiers in Bioscience, 3, d169-d175.
|
|
[27]
|
Arner, P. (2002) Insulin resistance in type 2 diabetes: Role of fatty acids. Diabetes/Metabolism Research and Re- views, 18, S5-S9. doi:10.1002/dmrr.254
|
|
[28]
|
Matsuzawa, Y., Shimomura, I., Nakamura, T., Keno, Y. and Tokunaga, K. (1994) Pathophysi-ology and pathoge- nesis of visceral fat obesity. Diabetes Re-search and Cli- nical Practice, 24, S111-S116.
doi:10.1016/0168-8227(94)90236-4
|
|
[29]
|
Das, U.N. (2006) Essential fatty acids: Biochemistry, phy- siology and pathology. Biotechnology Journal, 1, 420-439.
doi:10.1002/biot.200600012
|
|
[30]
|
Das, U.N. (2006) Essential fatty acids—A review. Cur- rent Pharmaceutical Biotechnology, 7, 467-482.
doi:10.2174/138920106779116856
|
|
[31]
|
Pettegrew, J.W., Panchalingam, K., Hamilton, R.L. and McClure, R.J. (2001) Brain membrane phospholipid al- terations in Alzheimer’s dis-ease. Neurochemical Research, 26, 771-782. doi:10.1023/A:1011603916962
|
|
[32]
|
Prasad, M.R., Lovell, M.A., Yatin, M., Dhillon, H. and Markesbery, W.R. (1998) Regional membrane phosphol-ipid alterations in Alzheimer’s disease. Neurochemical Research, 23, 81-88. doi:10.1023/A:1022457605436
|
|
[33]
|
Fewlass, D.C., Noboa, K., Pi-Sunyer, F.X., Johnston, J.M., Yan, S.D. and Tezapsidis, N. (2004) Obesity-related lep- tin regulates Alzheimer’s Abeta. FASEB Journal, 18, 1870-1878. doi:10.1096/fj.04-2572com
|
|
[34]
|
Considine, R.V., Sinha, M.K., Heiman, M.L., Kriauciunas, A., Stephens, T.W., Nyce, M.R., et al. (1996) Serum im- munoreactive-leptin concentrations in normal-weight and obese humans. The New England Journal of Medicine, 334, 292-295. doi:10.1056/NEJM199602013340503
|
|
[35]
|
Craft, S. (2007) Insulin resistance and Alzheimer’s dis- ease pathogenesis: Po-tential mechanisms and implica- tions for treatment. Current Alzheimer Research, 4, 147- 152. doi:10.2174/156720507780362137
|
|
[36]
|
Craft, S. (2005) Insu-lin resistance syndrome and Alzhei- mer’s disease: Age- and obesity-related effects on mem- ory, amyloid, and inflammation. Neurobiology of Aging, 26, 65-69. doi:10.1016/j.neurobiolaging.2005.08.021
|
|
[37]
|
Ho, L., Qin, W., Pompl, P.N., Xiang, Z., Wang, J., Zhao, Z., et al. (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. FASEB Journal, 18, 902-904.
|
|
[38]
|
Zhao, Z., Xiang, Z., Haroutunian, V., Buxbaum, J.D., Stetka, B. and Pasinetti, G.M. (2007) Insulin degrading enzyme activity selectively decreases in the hippo-campal formation of cases at high risk to develop Alzheimer’s disease. Neurobiology of Aging, 28, 824-830.
doi:10.1016/j.neurobiolaging.2006.05.001
|
|
[39]
|
Clandinin, M.T., Cheema, S., Field, C.J. and Baracos, V.E. (1993) Dietary lipids influence insulin action. Annals of the New York Academy of Sciences, 683, 151-163.
doi:10.1111/j.1749-6632.1993.tb35701.x
|
|
[40]
|
Storlien, L.H., Kriketos, A.D., Jenkins, A.B., Baur, L.A., Pan, D.A., Tapsell, L.C., et al. Does dietary fat influence insulin action? Annals of the New York Academy of Sci- ences, 827, 287-301.
doi:10.1111/j.1749-6632.1997.tb51842.x
|
|
[41]
|
Manco, M., Bertuzzi, A., Salinari, S., Scarfone, A., Cal- vani, M., Greco, A.V., et al. (2004) The ingestion of satu- rated fatty acid tria-cylglycerols acutely affects insulin se- cretion and insulin sen-sitivity in human subjects. British Journal of Nutrition, 92, 895-903.
doi:10.1079/BJN20041268
|
|
[42]
|
Hsu, C.P., Odewale, I., Al-cendor, R.R. and Sadoshima, J. (2008) Sirt1 protects the heart from aging and stress. Biological chemistry, 389, 221-231.
doi:10.1515/BC.2008.032
|
|
[43]
|
Borradaile, N.M. and Pickering, J.G. (2009) NAD(+), sirtuins, and cardiovascular disease. Current pharmaceutical design, 15, 110-117.
|
|
[44]
|
Stein, S. and Matter, C.M. (2011) Protective roles of SIRT1 in atherosclerosis. Cell Cycle, 10, 640-647.
doi:10.4161/cc.10.4.14863
|
|
[45]
|
Shi, Y., Camici, G.G. and Luscher, T.F. (2010) Cardio- vascular determinants of life span. European Journal of Physiology, 459, 315-324.
|
|
[46]
|
Purushotham, A., Schug, T.T., Xu, Q., Surapureddi, S., Guo, X. and Li, X. (2009) Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metabolism, 9, 327-338.
doi:10.1016/j.cmet.2009.02.006
|
|
[47]
|
Elliott, P.J. and Jirousek, M. (2008) Sirtuins: novel targets for metabolic disease. Current Opinion in Investigational Drugs, 9, 371-378.
|
|
[48]
|
Colak, Y., Ozturk, O., Senates, E., Tuncer, I., Yorulmaz, E., Adali, G., et al., SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease. International Medical Journal of Experimental and Clinical Research, 17, HY5-9.
|
|
[49]
|
Zhang, Z., Lowry, S.F., Guarente, L. and Haimovich, B. (2010) Roles of SIRT1 in the acute and restorative phases following induction of inflammation. The Journal of Bio- logical Chemistry, 285, 41391-41401.
doi:10.1074/jbc.M110.174482
|
|
[50]
|
Yoshizaki, T., Milne, J.C., Imamura, T., Schenk, S., So- noda, N., Babendure, J.L., et al., SIRT1 exerts anti-inflam- matory effects and improves insulin sensitivity in adipo- cytes. Molecular and Cellular Biology, 29, 1363-1374.
doi:10.1128/MCB.00705-08
|
|
[51]
|
Sasaki, T. and Kitamura, T. (2010) Roles of FoxO1 and Sirt1 in the central regulation of food intake. Endocrine Journal, 57, 939-946. doi:10.1507/endocrj.K10E-320
|
|
[52]
|
Michan, S., Li, Y., Chou, M.M., Parrella, E., Ge, H., Long, J.M., et al. (2010) SIRT1 is essential for normal cognitive function and synaptic plasticity. The Journal of Neurosci- ence, 30, 9695-9707.
|
|
[53]
|
Gao, J., Wang, W.Y., Mao, Y.W., Graff, J., Guan, J.S., Pan, L., et al. (2010) A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature, 466, 1105-1109. doi:10.1038/nature09271
|
|
[54]
|
Guarente, L., Mitochondria—A nexus for aging, calorie restriction, and sirtuins? Cell, 132, 171-176.
doi:10.1016/j.cell.2008.01.007
|
|
[55]
|
Libert, S., Cohen, D. and Guarente, L. (2008) Neurogenesis directed by Sirt1. Nature Cell Biology, 10, 373-374.
doi:10.1038/ncb0408-373
|
|
[56]
|
Silva, J.P. and Wahlestedt, C. (2010) Role of Sirtuin 1 in metabolic regulation. Drug Discovery Today, 15, 781-791.
doi:10.1016/j.drudis.2010.07.001
|
|
[57]
|
Schug, T.T. and Li, X. (2011) Sirtuin 1 in lipid metabo- lism and obesity. Annals of Medicine, 43, 198-211.
doi:10.3109/07853890.2010.547211
|
|
[58]
|
Cakir, I., Perello, M., Lansari, O., Messier, N.J., Vaslet, C.A. and Nillni, E.A. (2009) Hypothalamic Sirt1 regula- tes food intake in a rodent model system. PLoS One, 4, e8322. doi:10.1371/journal.pone.0008322
|
|
[59]
|
Guarente, L. (2007) Sirtuins in aging and disease. Cold Spring Harbor Symposia on Quantitative Biology, 72, 483-488. doi:10.1101/sqb.2007.72.024
|
|
[60]
|
Qin, W., Yang, T., Ho, L., Zhao, Z., Wang, J., Chen, L., et al. (2006) Neuronal SIRT1 activation as a novel mecha- nism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. The Jour- nal of Biological Chemistry, 281, 21745-21754.
doi:10.1074/jbc.M602909200
|
|
[61]
|
Pfluger, P.T., Herranz, D., Velasco-Miguel, S., Serrano, M. and Tschop, M.H. (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Pro-ceedings of the National Academy of Sciences of the United States of Amer- ica, 105, 9793-9798. doi:10.1073/pnas.0802917105
|
|
[62]
|
Deng, X.Q., Chen, L.L. and Li, N.X. (2007) The expres- sion of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats. Official Journal of the Interna- tional Association for the Study of the Liver, 27, 708-715.
|
|
[63]
|
Havel, P.J., Townsend, R., Chaump, L. and Teff, K. (1999) High-fat meals reduce 24-h circulating leptin concentra- tions in women. Diabetes, 48, 334-341.
doi:10.2337/diabetes.48.2.334
|
|
[64]
|
Lomb, D.J., Laurent, G. and Haigis, M.C. (2010) Sirtuins regulate key aspects of lipid metabolism. Biochimica et Biophysica Acta, 1804, 1652-1657.
doi:10.1016/j.bbapap.2009.11.021
|
|
[65]
|
Xie, H., Lim, B. and Lodish, H.F. (2009) MicroRNAs induced during adipogenesis that accelerate fat cell de- velopment are downregulated in obesity. Diabetes, 58, 1050-1057. doi:10.2337/db08-1299
|
|
[66]
|
Lee, Y.H., W.G. Tharp, R.L. Maple, S. Nair, P.A. Permana, and R.E. Pratley, Amyloid precursor protein expression is upregulated in adipocytes in obesity. Obesity, 2008. 16(7): p. 1493-500. doi:10.1038/oby.2008.267
|
|
[67]
|
Lee, Y.H., Martin, J.M., Maple, R.L., Tharp, W.G. and Pratley, R.E. (2009) Plasma amyloid-beta peptide levels correlate with adipocyte amyloid precursor protein gene expression in obese individuals. Neuroendocrinology, 90, 383-390. doi:10.1159/000235555
|
|
[68]
|
Leahey, T.M., Myers, T.A., Gunstad, J., Glickman, E., Spitznagel, M.B., Alexander, T., et al., Abeta40 is associ- ated with cognitive function, body fat and physical fitness in healthy older adults. Nutritional Neuroscience, 10, 205-209. doi:10.1080/10284150701676156
|
|
[69]
|
Holden, K.F., Lindquist, K., Tylavsky, F.A., Rosano, C., Harris, T.B. and Yaffe, K. (2009) Serum leptin level and cognition in the elderly: Findings from the health ABC study. Neurobiology of Aging, 30, 1483-1489.
doi:10.1016/j.neurobiolaging.2007.11.024
|
|
[70]
|
Gan, L. (2007) Therapeutic potential of sirtuin-activating compounds in Alz-heimer’s disease. Drug News & Per- spectives, 20, 233-239.
doi:10.1358/dnp.2007.20.4.1101162
|
|
[71]
|
Kim, D., Nguyen, M.D., Dobbin, M.M., Fischer, A., Sa- nanbenesi, F., Rodgers, J.T., et al. (2007) SIRT1 deacety- lase protects against neu-rodegeneration in models for Al- zheimer’s disease and amyo-trophic lateral sclerosis. EMBO Journal, 26, 3169-3179.
doi:10.1038/sj.emboj.7601758
|
|
[72]
|
Donmez, G., Wang, D., Cohen, D.E. and Guarente, L. (2010) SIRT1 suppresses beta-amyloid production by ac- tivating the alpha-secretase gene ADAM10. Cell, 142, 320-332. doi:10.1016/j.cell.2010.06.020
|
|
[73]
|
Garaulet, M., Esteban Tardido, A., Lee, Y.C., Smith, C.E., Parnell, L.D. and Ordovas, J.M. (2012) SIRT1 and CLOCK 3111T>C combined genotype is associated with evening preference and weight loss resistance in a beha- vioral therapy treatment for obesity. International Journal of Obesity.
|
|
[74]
|
Feige, J.N. and Auwerx, J. (2007) DisSIRTing on LXR and cholesterol metabolism. Cell Metabolism, 6, 343-345. doi:10.1016/j.cmet.2007.10.003
|
|
[75]
|
Li, X., Zhang, S., Blander, G., Tse, J.G., Krieger, M. and Guarente, L. (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Molecular Cell, 28, 91-106. doi:10.1016/j.molcel.2007.07.032
|
|
[76]
|
Cao, G., Bales, K.R., DeMattos, R.B. and Paul, S.M. (2007) Liver X recep-tor-mediated gene regulation and cholesterol homeostasis in brain: Relevance to Alzhei- mer’s disease therapeutics. Current Alzheimer Research, 4, 179-184. doi:10.2174/156720507780362173
|
|
[77]
|
Kawai, M. and Rosen, C.J. (2010) PPARgamma: A cir- cadian transcription factor in adipogenesis and osteoge- nesis. Nature Reviews Endocrinology, 6, 629-636.
doi:10.1038/nrendo.2010.155
|
|
[78]
|
Shimoyama, Y., Suzuki, K., Hamajima, N. and Niwa, T. (2011) Sirtuin 1 gene polymor-phisms are associated with body fat and blood pressure in Japanese. Translational Research, 157, 339-347. doi:10.1016/j.trsl.2011.02.004
|
|
[79]
|
Shimoyama, Y., Mitsuda, Y., Tsuruta, Y., Suzuki, K., Hamajima, N. and Niwa, T. (2012) SIRTUIN 1 gene polymorphisms are associated with cholesterol metabolism and coronary artery calcification in Japanese hemo-dialysis patients. Journal of Renal Nutrition, 22, 114-119.
doi:10.1053/j.jrn.2011.10.025
|
|
[80]
|
Clark, S.J., Falchi, M., Olsson, B., Jacobson, P., Cauchi, S., Balkau, B., et al. (2012) Association of sirtuin 1 (SIRT1) gene SNPs and transcript ex-pression levels with severe obesity. Obesity (Silver Spring), 20, 178-185.
doi:10.1038/oby.2011.200
|
|
[81]
|
Naqvi, A., Hoffman, T.A., DeRicco, J., Kumar, A., Kim, C.S., Jung, S.B., et al. (2010) A single-nucleotide varia- tion in a p53-binding site affects nutrient-sensitive human SIRT1 expression. Human Molecular Ge-netics, 19, 4123- 4133. doi:10.1093/hmg/ddq331
|
|
[82]
|
Flachsbart, F., Croucher, P.J., Nikolaus, S., Hampe, J., Cordes, C., Schreiber, S., et al. (2006) Sirtuin 1 (SIRT1) sequence variation is not associated with exceptional hu- man longevity. Experimental Gerontology, 41, 98-102.
doi:10.1016/j.exger.2005.09.008
|
|
[83]
|
Tsiotra, P.C. and Tsigos, C. (2006) Stress, the endoplas- mic reticulum, and insulin re-sistance. Annals of the New York Academy of Sciences, 1083, 63-76.
doi:10.1196/annals.1367.007
|
|
[84]
|
Li, Y., Xu, S., Giles, A., Nakamura, K., Lee, J.W., Hou, X., et al. (2011) Hepatic over-expression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resis- tance in the liver. FASEB Journal, 25, 1664-1679.
doi:10.1096/fj.10-173492
|
|
[85]
|
Jung, T.W., Lee, K.T., Lee, M.W. and Ka, K.H. (2012) SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygen-regulated protein 150. Bio-chemical and Biophysical Research Communications, 422, 229-232.
doi:10.1016/j.bbrc.2012.04.129
|
|
[86]
|
Marton, O., Koltai, E., Nyakas, C., Bakonyi, T., Zen- teno-Savin, T., Kumagai, S., et al. (2010) Aging and ex- ercise affect the level of protein acetylation and SIRT1 activity in cerebellum of male rats. Biogerontology, 11 679-686. doi:10.1007/s10522-010-9279-2
|
|
[87]
|
Ferrara, N., Rinaldi, B., Corbi, G., Conti, V., Stiuso, P., Boccuti, S., et al. (2008) Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Research, 11, 139-150. doi:10.1089/rej.2007.0576
|
|
[88]
|
Grant, W.B., Campbell, A., Itzhaki, R.F. and Savory, J. (2002) The significance of envi-ronmental factors in the etiology of Alzheimer’s disease. Journal of Alzheimers Disease, 4, 79-189.
|
|
[89]
|
Solfrizzi, V., Panza, F. and Capurso, A. (2003) The role of diet in cognitive decline. Journal of Neural Transmission, 110, 95-110.
|